Process for the preparation of (3-cyano-1H-indol-7-YL)(4-(4-fluorophe nethyl)piperazin-1-YL)-methanone and salts thereof

Details for Australian Patent Application No. 2002219220 (hide)

Owner Merck Patent GmbH

Inventors Bathe, Andreas; Crassier, Helene; Bottcher, Henning; Emmert, Steffen; Eckert, Uwe

Agent Davies Collison Cave

Pub. Number AU-B-2002219220

PCT Pub. Number WO2002/059092

Priority 101 02 944.6 23.01.01 DE

Filing date 21 December 2001

Wipo publication date 6 August 2002

Acceptance publication date 11 January 2007

International Classifications

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 1/14 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

A61P 27/06 (2006.01) Drugs for disorders of the senses

A61P 39/02 (2006.01) General protective or antinoxious agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 209/14 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/30 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/42 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-B-2002219220

11 January 2007 Application Accepted

  Published as AU-B-2002219220

10 May 2007 Standard Patent Sealed

19 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002219221-Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors

2002219219-Novel estrogen receptor ligands and methods I